This week's announcements include two CEO resignations at Nordic Nanovector and Verona Pharma, new CEOs at DalCor Pharmaceuticals and PureTech Health, new CMOs at Medigene, Argenx, Pneuma Respiratory and ReNeuron, plus board appointments.

The spring cherry blossom has ushered in a flurry of new executives to the industry in the Asia Pacific, particularly in Japan where the new fiscal years starts in April for most companies. GSK has taken a bold step to appoint an executive with a previous startup background to its senior leadership in Japan, while Daiichi Sankyo has set up a special division for overseas expansion. Nippon Shinyaku and IQVIA Japan have also made new appointments.

This week's company moves include the sudden departure of Celgene's COO, new CEOs at Abeona Therapeutics, Kleo Pharmaceuticals and Corvidia Therapeutics, while board appointments have been made at Neurocentrx, Hemogenyx Pharmaceuticals, Emergex Vaccines and Rezolute Inc.

Erez Israeli, ex-Teva long-timer, is set to take over as Dr Reddy’s chief operating officer and global head of the generics and PSAI (pharmaceuticals services and active ingredients) businesses. Israeli’s appointment comes at a time when the Indian firm tackles multiple operational challenges, including compliance issues at its plants.

This week's appointment announcements include a new chair at Menarini, a new president and COO, and a new CFO at Emergent BioSolutions, and other new hires at Novo Nordisk, Sienna Biopharmaceuticals, The Medicines Company and Dimerix.

This week's new appointments include the move by the second former big pharma executive to a PBM in the space of a week, plus a new CFO at Johnson & Johnson, and new CEOs at Alder BioPharmaceuticals, OncoMed and Hansa Medical. Other hires were announced by Astellas Americas, Merck & Co, Valbiotis, Bicycle Therapeutics, Sorrento Therapeutics, Gritstone Oncology and Oxford BioMedica. 

Takeda appoints a new chief financial official, the third in recent years, and a new consumer health CEO, while WuXi NextCode taps its COO to lead the genomics firm. Senior executives changes also take place at PAREXEL, Asahi Kasei Pharma, and Actelion Japan.

The latest biopharma industry personnel moves include a new executive hires at Roche, Lilly Oncology, Ipsen and Syros, a resignation at Five Prime, plus new board appointments at EUSA, Autolus and Forendo. 

The Swiss major has unveiled three new faces for its executive committee which include the firm's ethics head and its chief digital officer – Bertrand Bodson - who joined a couple of months ago, having implemented digital innovation and culture change in large non-pharma businesses such as Sainsbury's Argos, EMI and Amazon.

The latest biopharma industry appointments include a new chief patient officer at Servier, executives at Merck KGaA, Unum and Aduro, as well as several board updates.

The latest biopharma industry appointments include a new chairman at Bone Therapeutics, chief executives at SOTIO and Helsinn Therapeutics, new CFOs at Sobi, AMRI and at Blade Therapeutics, and a new CMO at Vertex Pharmaceuticals.